Eton Pharmaceuticals added to Russell 2000 and Russell 3000 Indexes

Eton Pharmaceuticals, Inc.

Effective after market close June 27, 2025 as part of 2025 annual reconstitution.
CEO Sean Brynjelsen called it a significant milestone recognizing shareholder value.
Addition expands visibility among index fund managers and institutional investors.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.